COLUMBIA, Md.--(BUSINESS WIRE)--CELSION CORPORATION (AMEX: CLN), a drug development company that is leveraging its technology platform to encapsulate and deliver a higher concentration of proven cancer killing drugs, today reported that It would hold a shareholders’ conference call at 11:00 a.m. Eastern Time on Thursday, November 8, 2007. To participate in the call, interested parties can dial 877-604-2080 (U.S./Canada) or 706-902-1383 (International), Conference ID: #23308858 to register ten minutes before the call is scheduled to begin. The call will also be broadcast live on the Internet at http://www.celsion.com.
